Actinic Keratosis Treatment Market Analysis 2025–2034: Care Pathways, Reimbursement Dynamics, and Key Demand Drivers
The actinic keratosis (AK) treatment market sits at the intersection of dermatology and skin cancer prevention, driven by persistent demand to treat sun-induced precancerous lesions before progression to invasive squamous cell carcinoma. AK is especially common in fair-skinned and aging